ArticleJCI insight2019

Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia.

Alessandro Matte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.